Antibody Engineering & Therapeutics 2020

GenScript Scientific Briefing:  GenScript's Cutting-Edge Technologies For Precision Engineering And COVID-19

• Date and Time: December 15^th at 2:00 EST
• Presenter: Marinella Sandros, Senior Global Product Manager

Book Now

Dr. Sandros will introduce GenScript's three core platforms supporting biological drug discovery and development research including

• Molecular Biology services - powered by next generation DNA synthesis technology, supporting gene synthesis and mutant library construction
• Protein services - high density expression system, supporting both protein and antibody production
• Antibody services - rabbit mAb generation technology (MonoRab™), supporting custom antibody production

As a contract research organization, GenScript relies on these advanced platforms to support different phases of drug discovery, from lead identification to validation and optimization as well as preclinical candidate evaluation.